What did @charliecaruso8 actually say?
The creator summarized a 50-day self-experiment in which someone took oral BPC-157, GHK-Cu, and CJC-1295 daily. The reported outcomes: lifts improved after two weeks, skin looked smoother within five days, facial scarring decreased, and physique appeared "a bit tighter." The creator's actual conclusion was refreshingly measured: "yes, these things can be utilized, but no, they're not needed." They also flagged that locking into nutrition and training during a self-experiment confounds any peptide-specific conclusions. That's a legitimate methodological point, and credit where it's due, most peptide content on TikTok skips that caveat entirely.
The video does not claim these peptides cure anything or recommend specific doses, which keeps it on the responsible side of the line. But there are still accuracy problems worth unpacking, particularly around the pharmacology of oral BPC-157 and the claim that taking GHK-Cu and CJC simultaneously reduces their individual effects.
Does the science back this up?
The research on these three peptides is at very different stages of development, and conflating them as a tidy stack misrepresents how preliminary most of this evidence actually is. BPC-157 has shown regenerative and anti-inflammatory effects in animal models, but human clinical trial data is almost nonexistent. GHK-Cu has more credible skin-biology research behind it. CJC-1295 affects growth hormone secretion in humans, but that comes with real regulatory and safety considerations that the video glosses over.
On oral BPC-157 specifically: peptides are chains of amino acids that get broken down in the gastrointestinal tract. Oral bioavailability is a genuine pharmacological problem. A 2022 review by Sikiric et al. in the journal Biomedicines argued for some GI-mediated stability of BPC-157, but this remains contested. Most of the compelling BPC-157 data comes from injectable or topical routes in rodents. Saying someone "felt stronger after two days" of oral BPC-157 is almost certainly a placebo or training effect, not a pharmacological one.
GHK-Cu has more grounded skin research. Studies by Pickart and Margolina (2018, Biomedicines) showed it promotes collagen synthesis and wound healing in cell and animal models. Five-day skin improvements in a self-report are hard to attribute cleanly, but the mechanism at least exists.
What did they get wrong (or right)?
The claim that using GHK-Cu and CJC "at the same time" makes "the effects of them both not as good" is presented as fact, but there's no published pharmacokinetic evidence for this specific interaction. It may be borrowed from anecdotal bodybuilding lore about receptor competition or timing protocols. GHK-Cu is a copper-binding tripeptide. CJC-1295 is a growth hormone-releasing hormone analogue. Their mechanisms are entirely different, and there's no peer-reviewed basis for claiming they negatively interfere with each other when co-administered. That's a misleading claim dressed up as insider knowledge.
What the creator got right: the confounding variable argument is solid. When people start a supplement protocol, they often simultaneously improve sleep, nutrition, and training consistency. Attributing results to the peptides alone is bad science. The creator explicitly said "nutrition" and "food and training" likely played a role. That's honest, and it's the kind of nuance that's genuinely rare in this content category.
The creator also avoided overclaiming on magnitude: "were the changes to his body astonishing? No." That's accurate, and it's a reasonable framing of what uncontrolled self-experiments can actually tell you, which is not much.
What should you actually know?
These three peptides sit in very different places scientifically and legally. CJC-1295 is a growth hormone secretagogue. The FDA removed several compounded peptides from the market in 2024 citing safety and efficacy concerns, and CJC-1295 has been on the restricted list for compounding pharmacies under certain classifications. Anyone pursuing CJC-1295 through a telehealth provider should ask direct questions about the regulatory status of what they're being prescribed and where it's sourced.
BPC-157 has genuine research interest, particularly for gut and tendon healing, but almost none of the human-applicable evidence supports the oral route used in this experiment. A 2021 review by Chang et al. in Current Pharmaceutical Design summarized the animal data positively while explicitly noting the absence of human randomized controlled trials.
GHK-Cu is the most commercially mature of the three, with established use in topical cosmetics. The skin-smoothing observation in the video is plausible, though a five-day timeline for structural skin changes should be viewed skeptically. Any peptide protocol should go through a licensed provider who can assess individual health status, not be reverse-engineered from a 60-second TikTok recap of someone else's self-experiment.